The Best Stock To Buy In 2017 May 2026

Outside of the S&P 500, small and mid-cap biotech companies saw even more explosive growth. Madrigal Pharmaceuticals led this category with a return in 2017. Madrigal Pharmaceuticals (MDGL): +516% Sangamo Therapeutics (SGMO): +438% Pieris Pharmaceuticals (PIRS): +437% Straight Path Communications (STRP): +436% Market Context and Sector Trends

The "best" stock to buy in 2017 depends on whether you were looking for the highest overall return, a top-performing blue chip, or a breakout biotech winner. In a year where the S&P 500 rose by approximately 19-20%, several stocks delivered triple-digit returns. The Top Overall Performers (S&P 500) the best stock to buy in 2017

Among the 30 blue-chip stocks in the Dow Jones Industrial Average, Boeing took first place, finishing roughly 20% ahead of the second-best performer, Caterpillar. Outside of the S&P 500, small and mid-cap